/Investor DB

Blue Bear Ventures

Venture capital

Berkeley · Pre-Seed–Series A · 6 people tracked

Find your way into Blue Bear Ventures

1,271 people in our graph share verified history with the Blue Bear Ventures team — schools, employers, funds. One of them is your warm intro.

Zuzanna Kompowskaunlockedknows Marianne Abib-Pech · together at Financial Times (overlapped)
knows the team · via National Institutes of Health
×10knows the team · via GE Capital
✨ Fox Verdict
Sign up to see your fit

Investment thesis

Blue Bear Ventures backs founders working at the frontiers of science and technology to solve pressing global challenges, focusing on deep tech companies spun out of leading research universities. The firm concentrates on sustainable economies, applied biology, and emerging technologies, and invests at the earliest stages. BBV emphasizes the strength of co-founding teams and early employees over ideas alone, and positions itself as a hands-on, trust-based partner and confidant rather than a metrics-driven investor. It supports portfolio companies across all areas from inception through their growth journey, providing mentorship, advisory help, and access to networks throughout the company's lifecycle.

Source: firm website, verified Sep 27, 2026.

What founders say

No founder feedback on Blue Bear Ventures yet.

Stage
Pre-Seed–Series A
Check
$100K – $400K
HQ
Berkeley, California, US
Leads rounds
Follows
Instruments
Equity
Founded
2017
Tracked investments
24
Unicorns
1
Acquisitions
1

Team · 6 people

from the firm's website & public directories

What they invest in

from 18 of 24 portfolio companies

Biotech ×10Deep Tech ×7Healthtech ×6Medical Devices ×6AI & Machine Learning ×5Hardware ×5Cleantech ×4Energy ×3

HQs:United States×13

Who they back

founder profiles across 11 portfolio companies
36%
solo founders
4 of 11 mapped founding teams
7%
repeat founders
of 15 founders with career history

Founding team size:solo founder×42 founders×63 founders×1

Where their founders studiedfrom 15 founders with education data

University of California, Berkeley ×4Massachusetts Institute of Technology ×2University of California, Santa Cruz ×2University of Colorado Boulder ×2

What their founders studiedfrom 15 founders with field-of-study data

Engineering ×8Computer Science ×4Life Sciences ×4Chemistry ×2Physics ×2

Where their founders worked beforefrom 15 founders with career history

UC Berkeley ×4NeuroBo Pharmaceuticals, Inc. ×2Simpatica Medicine, Inc. ×2Ucdavis ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×4

Investments · 24 tracked

founders shown can be your intro path

By year:2023 · 12022 · 12019 · 13 dated

Aether Bioaetherbio.comin𝕏

Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials

Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)

Co-investors4DX VenturesAbstract VenturesArtis VenturesBoxGroupCalm VenturesEvolution VC Partners+12 more

Alunaalunacare.com𝕏Acquired

Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases.

Digital HealthHealthtechMedical Devices

Charvi Shetty(Chief Executive Officer)inInderjit Jutla(Chief Scientific Officer)

Co-investorsGood Growth CapitalMatrixRho Capital PartnersRho VenturesZühlke VenturesSOSV

Ayar Labsayarlabs.comin𝕏

Ayar Labs develops co-packaged optics (CPO) technology for AI infrastructure, enabling optical connectivity between thousands of GPUs across data center racks.

AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US

Mark Wade(Founder & CEO)in

Co-investorsNVIDIAAlumni VenturesBasecamp FundBerkeley FrontierCastor VenturesFactorial Funds+17 more

BioAmp Diagnosticsbioampdx.com

BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.

BiotechDigital HealthMedical DevicesSan Carlos, US

Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in

Co-investorsBerkeley Angel NetworkIllumina Accelerator

BreezeBio Venture Capitalgenedit.comin𝕏

BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues.

BiotechDeep TechMedical Devices

Kunwoo Lee(Cofounder)in

Co-investorsBow CapitalIMM Investment JapanDCVC (Data Collective)

Clarityclarity.ioin𝕏

Clarity provides air quality sensing-as-a-service solutions, combining hardware air pollution sensors with cloud-based monitoring software and consulting services for organizations and communities measuring air quality.

CleantechClimate TechData & InfrastructureHardwareIoT

David Lu(Founder)in

BoardMinette NavarreteinRamanan RaghavendraninMarc Tarpenningin

Co-investorsKickstart VenturesSoundproof VenturesSpero VenturesHumba VenturesLMNT VenturesRegeneration.VC

Coreshellcoreshelltech.comin𝕏

CoreShell Technology develops metallurgical silicon materials for electric vehicle batteries as a more economical and scalable alternative to synthetic silicon.

CleantechEnergyNew Materials

Co-investorsBaruch Future VenturesEntrada VenturesFoothill VenturesHelios Climate VenturesTrousdale VenturesZeon Ventures

Correlia Biosystemscorreliabio.cominDefunct

Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL.

BiotechDeep TechHardwareHealthtechMedical DevicesSan Francisco, US

Akwasi Apori(Founder)inKursad Araz(Founder/CTO)inSamuel Tia(Founder)in

Co-investorsBeresford VenturesCota CapitalEndurance28Pallasite VenturesPangaea Ventures Us Inc.SV Latam Capital+11 more

DNA Litednalite.comin𝕏Apr 2022

Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.

BiotechDeep TechSan Francisco, US

Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)

BoardAndrew Cain McClary(Director)Drew Lanza(Director)in

Co-investorsBerkeley CatalystKdT Ventures

ImpriMedimprimedicine.comin𝕏

ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions.

AI & Machine LearningBiotechHealthtech

Co-investorsDFJ DragonFundDraper AssociatesHan River PartnersSazzeSk Telecom Venture Capital, Llc

Lockheed Martin Australialockheedmartin.comin

Lockheed Martin is a global security and aerospace company that develops military aircraft, missile defense systems, helicopters, radar and sensor systems, spacecraft, and cybersecurity capabilities for the U.S.

Deep TechDefense TechHardwareSpace TechBethesda, US

Jim Taicletin

Co-investorsDefence Trailblazer

NewSun Roadnewsunroad.comin𝕏May 2023

New Sun Road builds Stellar, a microgrid energy management platform combining Microgrid OS and Edge hardware that uses IoT data and AI to monitor, control, and optimize power systems such as solar and battery installations.

CleantechEnergyIoTRichmond, US

Jalel Sager(Director)inAustin Cappon(Director)inCandice Eggerss(Director)Adrienne Pierce(Executive Officer, Director)inChad Riley(Director)

BoardAndrew Karetsky(Director)

Co-investorsFocus Central AmericaSkyview Ventures

numericcal, inc.numericcal.com𝕏Defunct

Numericcal provides machine learning software for detecting anomalies, tracking assets, and managing workforce activities in automotive and manufacturing facilities, processing video and audio data across on-premises and cloud infrastructure to reduce operating costs.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Shaoyi Cheng(Founder)inranko sredojevic(Founder)in

Co-investorsY Combinator

Resynergiresynergi.comin

Resynergi converts plastic waste into recycled oil (PyOil) intended to achieve cost parity with conventional crude oil for use in plastics production.

Circular EconomyCleantechEnergyRohnert Park, US

Brian Bauer(Executive Officer, Director)in

Co-investorsTaranis

Synkrino Biotherapeuticssynkrino.bioin

Building new drugs to target inflammation using an AI + immunology discovery engine.

BiotechHealthtechSan Francisco, US

Jason Barbour(Founder/CEO)inDavid Ott(Founder/CTO)in

Co-investorsY CombinatorFundamental VenturesMicroVentures

Unnatural Productsunnaturalproducts.comin𝕏Sep 2019

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

BoardVasudev Bailey(Director)in

Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcDroia VenturesFirst Spark Ventures, Llc+6 more

YourChoiceyourchoicetx.com

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.

BiotechFemTechHealthtech

Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)

Co-investorsCivilization Ventures Management, LlcForeground CapitalFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more

YourChoice Therapeuticsychoicetx.comin

YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.

BiotechHealthtechMedical DevicesSan Francisco, US

Akash Bakshi(Founder)inNadja Mannowetz(Founder)in

Co-investorsForeground CapitalOlive Tree CapitalPortfoliaY Combinator8VCCleo Capital+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ANA TherapeuticsCypris MaterialsEngagelivelyImmulusMfluidx

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Blue Bear Ventures made?
Blue Bear Ventures has 24 tracked investments, 1 of which have exited.
What stage does Blue Bear Ventures invest at?
Blue Bear Ventures invests at the Pre-Seed, Seed, Series A stages.
What is Blue Bear Ventures's typical check size?
Blue Bear Ventures typically writes checks of $100K – $400K.
What sectors does Blue Bear Ventures focus on?
Blue Bear Ventures focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, New Materials, Robotics.
Where is Blue Bear Ventures located?
Blue Bear Ventures is headquartered in Berkeley, US.
Does Blue Bear Ventures lead rounds?
Blue Bear Ventures typically participates in rounds rather than leading them.
Who does Blue Bear Ventures co-invest with?
Blue Bear Ventures most often shares deals with Y Combinator, Abstract Ventures, Artis Ventures, among 73 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Deepak Gupta, Partner Blue Bear Ventures #buildfintechbusiness

FinTech Silicon Valley · Deepak Gupta

Similar investors

Featured in lists